| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing precisely ciprofloxacin (as ciprofloxacin lactate) 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin 100 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin 100 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 3 milligram/1 milliliter and fluocinolone acetonide 250 microgram/1 milliliter conventional release solution for ear drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only ciprofloxacin and fluocinolone in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only ciprofloxacin and fluocinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 3 milligram/1 milliliter conventional release solution for ear drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing ciprofloxacin and fluocinolone in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin (as ciprofloxacin hydrochloride) 574.9 mg and ciprofloxacin 425.2 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin (as ciprofloxacin hydrochloride) 574.9 mg and ciprofloxacin 425.2 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
2 |
| Ciprofloxacin (as ciprofloxacin hydrochloride) 574.9 mg and ciprofloxacin 425.2 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
2 |
| Product containing ciprofloxacin and fluocinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin hydrochloride monohydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
FHIR